Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Thoracic Malignancies (vol 11, 1612, 2023)
FI: 3,4
Tipo: Correction
Colaboración
Año: 2025
Autores
Hernández-Pedro, N; Arroyo-Hernández, M; Barrios-Bernal, P; Romero-Nuñez, E; Sosa-Hernandez, VA; Avila-Rios, S; Maravillas-Montero, JL; Perez-Padilla, R; de Miguel-Perez, D; Rolfo, C; Arrieta, O
Revista
Título: VACCINES
Cuartil
- Q2